Consainsights logo
Life Sciences

Overactive Bladder Treatment Market

Overactive Bladder Treatment Market by Pharmacotherapy (Anticholinergics, Mirabegron, Botox, Neurostimulation, Intravesical Instillation), Disease (Idiopathic Overactive Bladder, Neurogenic Overactive Bladder), Region, Trends, Competitive Analysis, and Growth Opportunities, Key Insights.
License Type
What you get?
  • Online view only
  • Delivered in 24-72 hours
  • Only a single designated user can access the report
  • 5 hours of analyst support

Executive Summary

Overactive Bladder Treatment Market from Consainsights analyses the Overactive Bladder Treatment Market in the Technology & Media industry over the forecast period to 2026.

Overactive Bladder Treatment research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Overactive Bladder Treatment segmentation includes Disease, Pharmacotherapy and Geography.

All segmentations encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Disease, the Overactive Bladder Treatment Market analysis covers Idiopathic Overactive Bladder, Neurogenic Overactive Bladder.

Based on the Pharmacotherapy, the Overactive Bladder Treatment Market analysis covers Anticholinergics, Botox, Intravesical Instillation, Mirabegron, Neurostimulation.

Key companies operating in the market include Medtronic Plc, Aurobindo Pharma Limited, Cogentix Medical, Inc., Macleods Pharmaceuticals Ltd., Johnson & Johnson, Intas Pharmaceuticals Ltd., Endo International Plc, Allergan, Plc., Mylan N.V., Sanofi, Pfizer, Inc., Astellas Pharma Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Limited, Apotex Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

Report Metric

Details

Market size available for years

2012-2027

Base year considered

2021

Forecast period

2022-2027

Forecast units

Value (USD Billion)

Segments covered

Disease, Pharmacotherapy

Geographies covered

North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

Companies Covered

Medtronic Plc, Aurobindo Pharma Limited, Cogentix Medical, Inc., Macleods Pharmaceuticals Ltd., Johnson & Johnson, Intas Pharmaceuticals Ltd., Endo International Plc, Allergan, Plc., Mylan N.V., Sanofi, Pfizer, Inc., Astellas Pharma Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Limited, Apotex Inc.


Table of Contents

  1. Executive Summary

  2. Overactive Bladder Treatment Market Overview

    1. Overactive Bladder Treatment Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Overactive Bladder Treatment Market 360° Synopsis: Overview
  3. Overactive Bladder Treatment Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. Overactive Bladder Treatment Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Overactive Bladder Treatment Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. Overactive Bladder Treatment Market: Disease

    1. Introduction
    2. Idiopathic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
    3. Neurogenic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
  6. Overactive Bladder Treatment Market: Pharmacotherapy

    1. Introduction
    2. Anticholinergics: Market Trends, Size, and Forecast (2017-2026)
    3. Botox: Market Trends, Size, and Forecast (2017-2026)
    4. Intravesical Instillation: Market Trends, Size, and Forecast (2017-2026)
    5. Mirabegron: Market Trends, Size, and Forecast (2017-2026)
    6. Neurostimulation: Market Trends, Size, and Forecast (2017-2026)
  7. Global Analysis

    1. Global Overactive Bladder Treatment Market, By Region, Y-O-Y Growth Analysis

      1. Introduction
      2. North America: Market Trends, Size, and Forecast (2017-2026)
      3. Europe: Market Trends, Size, and Forecast (2017-2026)
      4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
      5. Latin America: Market Trends, Size, and Forecast (2017-2026)
      6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
  8. Middle East & Africa Analysis

    1. Middle East & Africa Overactive Bladder Treatment Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Middle East: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Middle East Overactive Bladder Treatment Market: Disease
        3. Middle East Overactive Bladder Treatment Market: Pharmacotherapy
      3. Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Africa Overactive Bladder Treatment Market: Disease
        3. Africa Overactive Bladder Treatment Market: Pharmacotherapy
      4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Middle East & Africa Overactive Bladder Treatment Market: Disease
        3. Rest of Middle East & Africa Overactive Bladder Treatment Market: Pharmacotherapy
    2. Middle East & Africa Overactive Bladder Treatment Market, By Disease, Y-O-Y Growth Analysis

      1. Introduction
      2. Idiopathic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
      3. Neurogenic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
    3. Middle East & Africa Overactive Bladder Treatment Market, By Pharmacotherapy, Y-O-Y Growth Analysis

      1. Introduction
      2. Anticholinergics: Market Trends, Size, and Forecast (2017-2026)
      3. Botox: Market Trends, Size, and Forecast (2017-2026)
      4. Intravesical Instillation: Market Trends, Size, and Forecast (2017-2026)
      5. Mirabegron: Market Trends, Size, and Forecast (2017-2026)
      6. Neurostimulation: Market Trends, Size, and Forecast (2017-2026)
  9. North America Analysis

    1. North America Overactive Bladder Treatment Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. United States: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United States Overactive Bladder Treatment Market: Disease
        3. United States Overactive Bladder Treatment Market: Pharmacotherapy
      3. Canada: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Canada Overactive Bladder Treatment Market: Disease
        3. Canada Overactive Bladder Treatment Market: Pharmacotherapy
    2. North America Overactive Bladder Treatment Market, By Disease, Y-O-Y Growth Analysis

      1. Introduction
      2. Idiopathic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
      3. Neurogenic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
    3. North America Overactive Bladder Treatment Market, By Pharmacotherapy, Y-O-Y Growth Analysis

      1. Introduction
      2. Anticholinergics: Market Trends, Size, and Forecast (2017-2026)
      3. Botox: Market Trends, Size, and Forecast (2017-2026)
      4. Intravesical Instillation: Market Trends, Size, and Forecast (2017-2026)
      5. Mirabegron: Market Trends, Size, and Forecast (2017-2026)
      6. Neurostimulation: Market Trends, Size, and Forecast (2017-2026)
  10. Latin America Analysis

    1. Latin America Overactive Bladder Treatment Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Brazil: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Brazil Overactive Bladder Treatment Market: Disease
        3. Brazil Overactive Bladder Treatment Market: Pharmacotherapy
      3. Argentina: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Argentina Overactive Bladder Treatment Market: Disease
        3. Argentina Overactive Bladder Treatment Market: Pharmacotherapy
      4. Mexico: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Mexico Overactive Bladder Treatment Market: Disease
        3. Mexico Overactive Bladder Treatment Market: Pharmacotherapy
      5. Colombia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Colombia Overactive Bladder Treatment Market: Disease
        3. Colombia Overactive Bladder Treatment Market: Pharmacotherapy
      6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Latin America Overactive Bladder Treatment Market: Disease
        3. Rest of Latin America Overactive Bladder Treatment Market: Pharmacotherapy
    2. Latin America Overactive Bladder Treatment Market, By Disease, Y-O-Y Growth Analysis

      1. Introduction
      2. Idiopathic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
      3. Neurogenic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
    3. Latin America Overactive Bladder Treatment Market, By Pharmacotherapy, Y-O-Y Growth Analysis

      1. Introduction
      2. Anticholinergics: Market Trends, Size, and Forecast (2017-2026)
      3. Botox: Market Trends, Size, and Forecast (2017-2026)
      4. Intravesical Instillation: Market Trends, Size, and Forecast (2017-2026)
      5. Mirabegron: Market Trends, Size, and Forecast (2017-2026)
      6. Neurostimulation: Market Trends, Size, and Forecast (2017-2026)
  11. Asia-Pacific Analysis

    1. Asia-Pacific Overactive Bladder Treatment Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. China: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. China Overactive Bladder Treatment Market: Disease
        3. China Overactive Bladder Treatment Market: Pharmacotherapy
      3. Japan: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Japan Overactive Bladder Treatment Market: Disease
        3. Japan Overactive Bladder Treatment Market: Pharmacotherapy
      4. India: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. India Overactive Bladder Treatment Market: Disease
        3. India Overactive Bladder Treatment Market: Pharmacotherapy
      5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Southeast Asia Overactive Bladder Treatment Market: Disease
        3. Southeast Asia Overactive Bladder Treatment Market: Pharmacotherapy
      6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Australia & New Zealand Overactive Bladder Treatment Market: Disease
        3. Australia & New Zealand Overactive Bladder Treatment Market: Pharmacotherapy
      7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Asia-Pacific Overactive Bladder Treatment Market: Disease
        3. Rest of Asia-Pacific Overactive Bladder Treatment Market: Pharmacotherapy
    2. Asia-Pacific Overactive Bladder Treatment Market, By Disease, Y-O-Y Growth Analysis

      1. Introduction
      2. Idiopathic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
      3. Neurogenic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
    3. Asia-Pacific Overactive Bladder Treatment Market, By Pharmacotherapy, Y-O-Y Growth Analysis

      1. Introduction
      2. Anticholinergics: Market Trends, Size, and Forecast (2017-2026)
      3. Botox: Market Trends, Size, and Forecast (2017-2026)
      4. Intravesical Instillation: Market Trends, Size, and Forecast (2017-2026)
      5. Mirabegron: Market Trends, Size, and Forecast (2017-2026)
      6. Neurostimulation: Market Trends, Size, and Forecast (2017-2026)
  12. Europe Analysis

    1. Europe Overactive Bladder Treatment Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Germany: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Germany Overactive Bladder Treatment Market: Disease
        3. Germany Overactive Bladder Treatment Market: Pharmacotherapy
      3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United Kingdom Overactive Bladder Treatment Market: Disease
        3. United Kingdom Overactive Bladder Treatment Market: Pharmacotherapy
      4. France: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. France Overactive Bladder Treatment Market: Disease
        3. France Overactive Bladder Treatment Market: Pharmacotherapy
      5. Spain: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Spain Overactive Bladder Treatment Market: Disease
        3. Spain Overactive Bladder Treatment Market: Pharmacotherapy
      6. Russia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Russia Overactive Bladder Treatment Market: Disease
        3. Russia Overactive Bladder Treatment Market: Pharmacotherapy
      7. Italy: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Italy Overactive Bladder Treatment Market: Disease
        3. Italy Overactive Bladder Treatment Market: Pharmacotherapy
      8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Europe Overactive Bladder Treatment Market: Disease
        3. Rest of Europe Overactive Bladder Treatment Market: Pharmacotherapy
    2. Europe Overactive Bladder Treatment Market, By Disease, Y-O-Y Growth Analysis

      1. Introduction
      2. Idiopathic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
      3. Neurogenic Overactive Bladder: Market Trends, Size, and Forecast (2017-2026)
    3. Europe Overactive Bladder Treatment Market, By Pharmacotherapy, Y-O-Y Growth Analysis

      1. Introduction
      2. Anticholinergics: Market Trends, Size, and Forecast (2017-2026)
      3. Botox: Market Trends, Size, and Forecast (2017-2026)
      4. Intravesical Instillation: Market Trends, Size, and Forecast (2017-2026)
      5. Mirabegron: Market Trends, Size, and Forecast (2017-2026)
      6. Neurostimulation: Market Trends, Size, and Forecast (2017-2026)
  13. Overactive Bladder Treatment Market: Company Analysis

    1. Introduction
    2. Medtronic Plc

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights
    3. Aurobindo Pharma Limited

    4. Cogentix Medical, Inc.

    5. Macleods Pharmaceuticals Ltd.

    6. Johnson & Johnson

    7. Intas Pharmaceuticals Ltd.

    8. Endo International Plc

    9. Allergan, Plc.

    10. Mylan N.V.

    11. Sanofi

    12. Pfizer, Inc.

    13. Astellas Pharma Inc.

    14. Hisamitsu Pharmaceutical Co., Inc.

    15. Teva Pharmaceutical Industries Limited

    16. Apotex Inc.

  14. Overactive Bladder Treatment Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  15. Overactive Bladder Treatment Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  16. Industry & Analysts Insights for Success

  17. Research Methodology

  18. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures & Tables

List of Figures

Figure: Global Overactive Bladder Treatment Market: Structure

Figure: Global Overactive Bladder Treatment Market: Value Chain Analysis

Figure: Global Overactive Bladder Treatment Market: Porter's Five Forces Model

Figure: Global Overactive Bladder Treatment Market: Market Dynamics

Figure: Global Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: North America Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: Europe Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: Asia-Pacific Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: Latin America Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: Middle East & Africa Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: Global Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: North America Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: Europe Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: Asia-Pacific Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: Latin America Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

Figure: Middle East & Africa Overactive Bladder Treatment Market, By Overactive Bladder Treatment, 2022-2027 (USD Million)

List of Tables

Table: Global Overactive Bladder Treatment Market, By Disease, 2017-2026 (USD Million)

Table: North America Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: United States Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Canada Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Europe Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Germany Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: United Kingdom Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: France Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Spain Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Russia Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Italy Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Rest of Europe Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Asia-Pacific Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: China Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Japan Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: India Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Southeast Asia Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Australia & New Zealand Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Latin America Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Brazil Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Argentina Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Mexico Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Colombia Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Rest of Latin America Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Middle East & Africa Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Middle East Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Africa Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Overactive Bladder Treatment Market, By Disease, 2022-2027 (USD Million)

Table: Global Overactive Bladder Treatment Market, By Pharmacotherapy, 2017-2026 (USD Million)

Table: North America Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: United States Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Canada Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Europe Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Germany Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: United Kingdom Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: France Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Spain Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Russia Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Italy Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Rest of Europe Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Asia-Pacific Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: China Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Japan Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: India Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Southeast Asia Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Australia & New Zealand Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Rest of Asia-Pacific Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Latin America Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Brazil Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Argentina Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Mexico Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Colombia Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Rest of Latin America Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Middle East & Africa Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Middle East Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Africa Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)

Table: Rest of Middle East & Africa Overactive Bladder Treatment Market, By Pharmacotherapy, 2022-2027 (USD Million)